Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

BioNTech
Biotech

BioNTech’s mRNA cancer vaccine fails phase 3 test

With immature OS data offering a path to redemption, the German biotech is continuing to track patients in the metastatic head and neck cancer study.
Nick Paul Taylor Oct 13, 2026 8:48am
two arrows pointing different directions

Paragon Labs imports Apogee leadership after AbbVie buyout

Oct 13, 2026 8:44am
iRegene Therapeuticss NouvSight001 Cleared for Clinical Trials in the US and China for Retinitis Pigmentosa

iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa

Brought to you by iRegene Therapeutics
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: Soufflé & more

Oct 13, 2026 8:00am
video
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
Roche

Roche inks $1.16B Rona deal to enter emerging obesity race

Oct 13, 2026 7:45am